National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 2) (PB 15 of 2015) (Cth)

PB 15 of 2015

National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 2)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary , Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated             24            February 2015

ADRIANA PLATONA

Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 2).

   (2)   This Determination may also be cited as PB 15 of 2015.

2. Commencement

   This Determination commences on 1 March 2015.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Clostridium botulinum toxin type A toxin-haemagglutinin complex

Insert

Coal tar

[2]     Schedule 1, after item dealing with Peginterferon alfa-2a

Insert

Peginterferon Beta-1a

[3]     Schedule 1, after item dealing with Phenytoin

Insert

Phytomenadione